SCHEDULE: Vanguard Group Reports Zero Beneficial Ownership in Health Catalyst

The Vanguard Group has filed an amended Schedule 13G, indicating 0% beneficial ownership in Health Catalyst Inc. following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 8 to Schedule 13G for Health Catalyst Inc.
• The filing reports that The Vanguard Group now beneficially owns 0% of Health Catalyst Inc.'s Common Stock.
• This change is due to an internal realignment within The Vanguard Group, effective January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of Vanguard will report beneficial ownership separately.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities held by these disaggregated entities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is an administrative update regarding beneficial ownership reporting by The Vanguard Group, not a reflection of Health Catalyst Inc.'s operational or financial performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors holding significant stakes. The Vanguard Group's internal realignment leading to disaggregated reporting is an administrative change, not indicative of a change in investment strategy or sentiment towards Health Catalyst Inc. by Vanguard's underlying funds, which will now report separately.

Stakeholder Impact

• Minimal direct impact on Health Catalyst Inc. shareholders, as the change reflects an internal reporting adjustment by The Vanguard Group rather than a divestment or change in investment thesis by the underlying funds.

Key Dates

Keywords

Health Catalyst Inc, Vanguard Group, Schedule 13G, beneficial ownership, internal realignment, common stock, investment adviser